Search Results

There are 13384 results for: content related to: 5-HT 4 receptor agonists: similar but not the same

  1. You have free access to this content
    The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

    British Journal of Pharmacology

    Volume 143, Issue 5, November 2004, Pages: 549–560, D T Beattie, J A M Smith, D Marquess, R G Vickery, S R Armstrong, T Pulido-Rios, J L McCullough, C Sandlund, C Richardson, N Mai and P P A Humphrey

    Version of Record online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0705929

  2. You have free access to this content
    Porcine left atrial and sinoatrial 5-HT4 receptor-induced responses: fading of the response and influence of development

    British Journal of Pharmacology

    Volume 147, Issue 2, January 2006, Pages: 140–157, Joris H De Maeyer, Roel Straetemans, Jan A J Schuurkes and Romain A Lefebvre

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706497

  3. You have free access to this content
    A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors

    British Journal of Pharmacology

    Volume 150, Issue 6, March 2007, Pages: 782–791, R G Vickery, N Mai, E Kaufman, D T Beattie, T Pulido-Rios, M O'Keefe, P P A Humphrey and J A M Smith

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707154

  4. You have free access to this content
    Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation

    Neurogastroenterology & Motility

    Volume 26, Issue 12, December 2014, Pages: 1761–1770, M. Gilet, H. Eutamene, H. Han, H. W. Kim and L. Bueno

    Version of Record online : 15 OCT 2014, DOI: 10.1111/nmo.12458

  5. You have full text access to this OnlineOpen article
    Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 7, April 2012, Pages: 745–767, J. Tack, M. Camilleri, L. Chang, W. D. Chey, J. J. Galligan, B. E. Lacy, S. Müller-Lissner, E. M. M. Quigley, J. Schuurkes, J. H. De Maeyer and V. Stanghellini

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2036.2012.05011.x

  6. You have free access to this content
    Neurogastroenterology of tegaserod (HTF 919) in the submucosal division of the guinea-pig and human enteric nervous system

    Neurogastroenterology & Motility

    Volume 20, Issue 1, January 2008, Pages: 80–93, X. Fang, S. Liu, X-y. Wang, N. Gao, H-z. Hu, G-d. Wang, C. H. Cook, B. J. Needleman, D. J. Mikami, Y. Xia, G-j. Fei, G. A. Hicks and J. D. Wood

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1365-2982.2007.00983.x

  7. You have free access to this content
    Activation of peripheral 5-HT4 receptors attenuates colonic sensitivity to intraluminal distension

    Neurogastroenterology & Motility

    Volume 18, Issue 1, January 2006, Pages: 76–86, B. Greenwood-van Meerveld, K. Venkova, G. Hicks, E. Dennis and M. D. Crowell

    Version of Record online : 14 OCT 2005, DOI: 10.1111/j.1365-2982.2005.00723.x

  8. You have free access to this content
    Tegaserod

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 3, March 2001, Pages: 277–289, M. Camilleri

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1365-2036.2001.00925.x

  9. You have free access to this content
    Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats

    British Journal of Pharmacology

    Volume 158, Issue 5, November 2009, Pages: 1210–1226, Evelin Painsipp, Anaid Shahbazian and Peter Holzer

    Version of Record online : 28 SEP 2009, DOI: 10.1111/j.1476-5381.2009.00392.x

  10. You have free access to this content
    Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 11-12, December 2005, Pages: 1047–1060, B. D. CASH and W. D. CHEY

    Version of Record online : 14 NOV 2005, DOI: 10.1111/j.1365-2036.2005.02696.x

  11. You have free access to this content
    Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity

    Neurogastroenterology & Motility

    Volume 19, Issue s1, January 2007, Pages: 89–119, L. Bueno, F. De Ponti, M. Fried, G. A. Kullak-ublick, M. A. Kwiatek, D. Pohl, E. M. M. Quigley, J. Tack and N. J. Talley

    Version of Record online : 3 JAN 2007, DOI: 10.1111/j.1365-2982.2006.00876.x

  12. You have free access to this content
    Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue s7, November 2004, Pages: 3–14, M. D. Gershon

    Version of Record online : 1 NOV 2004, DOI: 10.1111/j.1365-2036.2004.02180.x

  13. You have free access to this content
    Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist

    Neurogastroenterology & Motility

    Volume 21, Issue 11, November 2009, Pages: 1197–e108, K. Campbell-dittmeyer, G. A. Hicks, D. L. Earnest and B. Greenwood-van Meerveld

    Version of Record online : 3 FEB 2009, DOI: 10.1111/j.1365-2982.2008.01238.x

  14. You have free access to this content
    5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors

    Neurogastroenterology & Motility

    Volume 17, Issue 5, October 2005, Pages: 637–642, M. Tonini

    Version of Record online : 1 SEP 2005, DOI: 10.1111/j.1365-2982.2005.00716.x

  15. You have free access to this content
    5-HT receptors and visceral hypersensitivity – 2B or not 2B, that is the question?

    Neurogastroenterology & Motility

    Volume 18, Issue 5, May 2006, Pages: 339–342, D. Grundy

    Version of Record online : 28 MAR 2006, DOI: 10.1111/j.1365-2982.2006.00777.x

  16. You have free access to this content
    The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 11, November 2000, Pages: 1503–1509, P. J. Kahrilas, E. M. M. Quigley, D. O. Castell and S. J. Spechler

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00854.x

  17. You have free access to this content
    Importance of 5-hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity

    Neurogastroenterology & Motility

    Volume 19, Issue s2, August 2007, Pages: 13–18, B. Greenwood-van Meerveld

    Version of Record online : 6 JUL 2007, DOI: 10.1111/j.1365-2982.2007.00964.x

  18. You have free access to this content
    The effects of tegaserod, a 5-HT4 receptor agonist, on gastric emptying in a murine model of diabetes mellitus

    Neurogastroenterology & Motility

    Volume 17, Issue 5, October 2005, Pages: 738–743, M. D. Crowell, C. Mathis, V. A. Schettler, T. Yunus and B. E. Lacy

    Version of Record online : 21 JUN 2005, DOI: 10.1111/j.1365-2982.2005.00681.x

  19. You have free access to this content
    5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity

    Neurogastroenterology & Motility

    Volume 18, Issue 5, May 2006, Pages: 343–345, B. Greenwood-van meerveld, K. Campbell-dittmeyer, A. C. Johnson and G. A. Hicks

    Version of Record online : 23 FEB 2006, DOI: 10.1111/j.1365-2982.2006.00767.x

  20. You have free access to this content
    Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to Tegaserod

    Basic & Clinical Pharmacology & Toxicology

    Volume 106, Issue 5, May 2010, Pages: 416–421, Silvia Suffredini, Elisabetta Cerbai, Gabriele Giunti, Mohamed El Mouelhi, Hans-Jürgen Pfannkuche and Alessadro Mugelli

    Version of Record online : 30 DEC 2009, DOI: 10.1111/j.1742-7843.2009.00507.x